A study analysing effects of Fenfluramine on patients with Dravet syndrome and their families
Latest Information Update: 06 Sep 2022
At a glance
- Drugs Fenfluramine (Primary)
- Indications Dravet syndrome
- Focus Therapeutic Use
- 01 Sep 2022 Results assessing real-world benefits on quality of life from the caregiver perspective, published in the Epilepsy Research.
- 01 Sep 2021 Results of a quantitative analysis assessed how Fenfluramine treatment affects quality of life of Dravet Syndrome patients and their families presented at the 34th International Epilepsy Congress
- 21 Jan 2021 New trial record